
    
      Up to 48 healthy volunteers will be given a single dose of AG10 or placebo and be monitored
      for safety and tolerability over a 5-day period. Up to 48 healthy volunteers will be given
      multiple doses of AG10 or placebo and be monitored for safety and tolerability over a 15-day
      period.
    
  